Featured

Top 100 Global Innovators for 2023 revealed [Report]

Ed White

Principal Analyst and VP

arrow_forward Read more
Biopharma
The Drugs to Watch in 2023
arrow_forward Read more
Academia and Government
Highly Cited Researchers 2022: Using deeper qualitative analysis to help spot research misconduct
arrow_forward Read more
Life Sciences and Healthcare
May 15, 2020

Applying regulatory flexibility in the age of COVID-19
Dr. Jenny Sharpe
Senior Scientific Writer, Centre for Innovation in Regulatory Science
Clarivate
Life Sciences and Healthcare
April 28, 2020

Key Disruptors in The Multiple Myeloma Landscape: 2020 and Beyond
Biopharma customer engagement
Life Sciences and Healthcare
April 24, 2020

COVID-19 Pandemic: Current Status and Medtech Impact
Life Sciences and Healthcare
April 17, 2020

Four NMEs Hope to Keep Up Momentum in the U.S. Migraine Market
Life Sciences and Healthcare
April 13, 2020

Synergy Between AI and Digital Platforms for PBMs; Driving Value-Based Programs
Life Sciences and Healthcare
April 7, 2020

The COVID-19 pandemic: European regulators respond
Monia Tumminello
Manager, Cortellis Regulatory Intelligence
Clarivate
Life Sciences and Healthcare
April 7, 2020

Combating COVID-19: Insights from the BIO Europe conference
Life Sciences and Healthcare
April 6, 2020

Patient access week 2020: Thank you to everyone on the front lines!
Life Sciences and Healthcare
April 3, 2020

Impact of COVID-19: 4 challenges life science companies face
Life Sciences and Healthcare
March 31, 2020

Treating a pandemic: Drug repurposing, expanded access and emergency use authorization
Meg Egan-Auderset
Medical & Regulatory Writer, Cortellis
Clarivate
Life Sciences and Healthcare
March 31, 2020

The trials must go on: Conducting clinical studies during the COVID-19 pandemic
Jaime Polychrones
Medical Writer, Cortellis Regulatory Intelligence
Clarivate
Life Sciences and Healthcare
March 31, 2020

FDA to expedite public release of guidance documents related to COVID-19
Meg Egan-Auderset
Medical & Regulatory Writer, Cortellis
Clarivate
Life Sciences and Healthcare
March 31, 2020

FDA unveils emergency investigational COVID-19 convalescent plasma application program
Julie Odland
Medical & Regulatory Writer, Cortellis
Clarivate
Clarivate Insights
March 25, 2020

COVID-19: Scientific innovation will help us beat this virus
Shaheen Jaffar
Associate Manager
Clarivate
Life Sciences and Healthcare
March 25, 2020

Do EMA and FDA review outcomes for new active substances (NASs) align?